$5.930
-0.040 (-0.67%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
Loading chart…
STLN 株は買うべき？
Starling Oncology, Inc. is not a good buy right now due to its negative fundamentals and recent performance. The current price is $6.17, and the forward P/E ratio is 0, indicating no expected earnings growth. Additionally, the stock has seen a 5-day change of -4.56%, suggesting a downward trend. The primary risk is the negative P/E ratio of -17.80, which indicates the company is currently unprofitable.
STLN の株価は Friday に $5.93 で引け、その前に下落 -0.67%
(STLN) last closed at $5.93, losing -0.67%. These facts feed the 1-day and 1-week STLN price prediction above.
予想の要因
STLN（STLN）の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Seasonality
Positive
Bullish
STLN の季節性分析
Loading chart…
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。